Today: 5 February 2026
Subscribe
Browse Category

NYSE:CNP News 4 December 2025 - 6 December 2025

Palantir (PLTR) Stock Forecast: Nvidia Deal, Rodeo AI and ICE Furor on December 6, 2025

Palantir (PLTR) Stock Forecast: Nvidia Deal, Rodeo AI and ICE Furor on December 6, 2025

Palantir Technologies (NASDAQ: PLTR) is ending the week as one of the most hotly debated AI stocks on Wall Street. The share price is hovering around $181.76, up about 2% on the day and sitting not far below its recent 52‑week high of $207.52, giving the data analytics and AI specialist a market capitalization of roughly $430 billion. MarketBeat After…
6 December 2025
·······
CenterPoint Energy (CNP) Stock Outlook: Latest News, Forecasts and Catalysts as of December 4, 2025

CenterPoint Energy (CNP) Stock Outlook: Latest News, Forecasts and Catalysts as of December 4, 2025

CenterPoint Energy, Inc. (NYSE: CNP) remains in the spotlight as utilities race to meet surging electricity demand from AI data centers, population growth and ongoing grid-hardening efforts. As of December 4, 2025, CenterPoint’s share price trades around $38.38, leaving the stock a few percentage points below its 52‑week high and roughly in line with Wall Street’s “steady grower” expectations. MarketWatch…
4 December 2025
·····

Stock Market Today

  • Morguard North American Residential REIT Stock Surges Above 200-Day Moving Average
    February 5, 2026, 5:12 AM EST. Morguard North American Residential Real Estate Investment Trust (TSE:MRG.UN) stock price climbed above its 200-day moving average of C$17.89, reaching a high of C$18.38 on Wednesday. The REIT, focusing on multi-suite residential rentals in Canada and the U.S., last traded at C$18.32 with 42,344 shares changing hands. Brokerages remain cautiously optimistic, with Royal Bank of Canada downgrading the rating to "sector perform" but raising the price target to C$21, while TD Securities lifted their target to C$24 and maintained a "buy" rating. The stock carries a market cap near C$957 million and a low price-to-earnings ratio of 5.24, indicating undervaluation. Morguard's U.S. segment drives most revenue. Analysts give a consensus of "Moderate Buy" with an average price target of C$22.33.
Go toTop